Watch Demo

Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
  • Publish Date:March 2023

  • Number of Pages:146

  • Report ID:6185677

  • Format:PDF

  • Publisher:IMARC Group

$ 2499


The global biologics market size reached US$ 321.0 Billion in 2022. Looking forward, the analyst expects the market to reach US$ 535.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Biologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of components of living organisms. They include a wide variety of products, such as vaccines, blood, blood components, cells, genes, tissues, allergens, and recombinant proteins, derived from humans, animals, birds, insects, plants, and microorganisms. These products control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system. They also change the manner of operation of natural biologic intracellular and cellular actions. In recent years, biologics have gained immense traction as they are essentially utilized to treat various diseases and conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases.

Biologics Market Trends:
The global biologics market is primarily driven by the rising incidences and diagnosis of chronic diseases that have necessitated the availability of advanced diagnostics and treatment drugs. Biologics are genetically engineered to target a specific part of the immune system that fuels inflammation. Governments of different countries are also taking initiatives to promote the healthcare sector and ensure the availability of biologics with the onset of coronavirus disease (COVID-19). Furthermore, scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biological products. Moreover, various pharmaceutical companies are undertaking research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn’s diseases.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on source, product, disease and manufacturing.

Breakup by Source:Microbial

Breakup by Product:
Monoclonal Antibodies
Recombinant Proteins
Antisense, RNAi and Molecular Therapy

Breakup by Disease:
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders

Breakup by Manufacturing:

Breakup by Region:
North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi.

Key Questions Answered in This Report

1. What was the size of the global biologics market in 2022?
2. What is the expected growth rate of the global biologics market during 2023-2028?
3. What are the key factors driving the global biologics market?
4. What has been the impact of COVID-19 on the global biologics market?
5. What is the breakup of the global biologics market based on the source?
6. What is the breakup of the global biologics market based on the product?
7. What is the breakup of the global biologics market based on the disease?
8. What is the breakup of the global biologics market based on the manufacturing?
9. What are the key regions in the global biologics market?
10. Who are the key players/companies in the global biologics market?

Table of contents

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down...


Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.